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Human endogenous retroviruses (HERVs) are transcribed in many cancers including
prostate cancer. Human endogenous retrovirus K (HERV-K) of the HML2 subtype is the
most recently integrated and most intact retrovirus in the human genome, with many of the
viral genomes encoding full- or partial-length viral proteins. To assess transcripts of HERV-
K in prostate cancer cell lines and identify the specific HERV-K elements in the human
genome that are transcribed, reverse transcriptase-PCR (RT-PCR) and cDNA sequenc-
ing were undertaken. Strand-specific RT-PCR, plasmid subcloning, and cDNA sequencing
detected the presence of HERV-K(HML2) coding strand transcripts within four prostate
cell lines (LNCaP, DU145, PC3, and VCaP). RT-PCR across splice junctions revealed splic-
ing variants for env gene mRNA in three cell lines, two involving previously undescribed
alternative splice sites. To determine the HERV-K loci from which the transcripts arose,
RepeatMasker was used to compile a list of over 200 HERV-K internal genome segment
fragments and over 1,000 HERV-K solo long terminal repeat (LTR) fragments in the human
genome. Surprisingly, the sequences identified from internal positions of the viral genome
were mostly smaller segments, while the LTRs were relatively intact. Possible reasons for
this are discussed. The transcripts in the cell lines tested, arose from several HERV-K loci,
with some proviruses being detected in multiple cell lines and others in only one of the
four used. In some instances, transcripts from viral antisense strands was also detected.
In addition, transcripts from both strands of solo LTRs were detected. These data show
that transcripts from HERV-K loci commonly occur in prostate cancer cell lines and that
transcription of either strand can occur. They also emphasize the importance of single
nucleotide level analysis to identify the specific, individual HERV-K loci that are transcribed,
and indicate that HERV-K expression in prostate cancer warrants further study.
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INTRODUCTION
Human Endogenous Retroviruses (HERVs) exist as the integrated
form of retrovirus DNA, called proviruses, at many loci in the
human genome. They are the result of ancient retroviral infec-
tions of the human germline cells during evolution (1). There are
many different species of endogenous retroviruses in the humans
today, and collectively they comprise about 8% of the human
genome. Since the divergence of the human and chimpanzee lin-
eages approximately six million years ago, the only retrovirus
known to have entered the genome of the human lineage is
the HML2 subset of human endogenous retrovirus K (HERV-K)
(2–8). Since it is the newest HERV, HERV-K(HML2) thus has had
the least time to accumulate mutations and constitutes the most
intact set of retrovirus in the human genome (2, 9–16). Some
HERV-K(HML2) proviruses entered the germline of the human
lineage earlier in evolutionary time in the common ancestors of
humans and other catarrhines (2, 17–19). In the absence of selec-
tion pressure on the host to maintain the proviral genomes in
an intact form, recombination events, and various other types
of mutations inevitably accumulate in the proviruses over evo-
lutionary time. The most common mutation of HERV-K is the
formation of solo long terminal repeats (LTRs), which occurs by
homologous recombination between the two LTRs of an individual
provirus (16, 20). For HERV-K, solo LTRs outnumber proviruses
by more than 10 to 1 (16). No HERV-K proviral locus has been
found that produces fully functional, infectious virions, although
the components to assemble an infectious virus genome exist
in the human genome today (14). There are over 1,000 HERV-
K(HML2)-containing loci in the human genome today, that range
from solo LTRs and fragments of proviruses to almost intact, full-
length proviruses. Many of the HERV-K proviruses are sufficiently
intact to encode functional proteins (2, 12–16), and these proteins
have been suggested to contribute to diseases including cancers
(21–25, 39).
Human endogenous retrovirus K is transcribed to various
extents in several human diseases including cancer (26–30), HIV
infection (31–35), and autoimmune disorders (36, 37). Human-
specific HERV-K(HML2) elements in the human genome are
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approximately 99% identical in pairwise comparisons to each
other, and many of the differences among them are single base
pair changes. Thus the techniques used to detect HERV-K tran-
scription often do not allow a determination of which spe-
cific viral loci in the human genome were the source of the
detected RNAs. Individual loci differ in the integrity of spe-
cific open reading frames (ORFs), functionality of the encoded
proteins, and the capacity of DNA sequences flanking the viral
DNA as well as unique mutations within individual loci to
affect transcription. In certain instances, transcription of spe-
cific HERV-K loci has been recognized (38–41), although for
most HERV-K loci, particularly solo LTRs, HERV-K transcrip-
tion has not been assessed. In addition, many HERV-K loci are
situated within introns of genes, often in the reverse transcrip-
tional orientation, and they may be transcribed as a segment of
the gene being expressed (42). Transcription of multiple HERV
types including HERV-K was reported in human prostate can-
cer (PrCa) and occurs to varying extents (43–46). To under-
stand the biological role, if any, and potentially to predict func-
tionality of HERV-K in human diseases, a thorough analysis
of viral transcription that includes solo LTRs, viral fragments,
DNA strand, and genomic loci of origin is necessary. As a step
toward these ultimate goals, we analyzed four PrCa cell lines
by strand-specific reverse transcriptase-PCR (RT-PCR). Sequenc-
ing of PCR products was used to determine the loci of specific
transcripts.
RESULTS
HERV-K LOCI IN HUMAN GENOME
To define the loci of origin for individual HERV-K transcripts, it
was first necessary to generate a comprehensive list of the HERV-
K segments in the human genome. This was accomplished using
the Table Browser tool (47) at UCSC Genome Browser (48) and
the GRCh37/hg19 human genome assembly. The sequences and
genomic positions of LTR and internal genome segments were
downloaded using RepeatMasker (49) and RepBase definitions
(50) for LTR5_Hs, LTR5A, or LTR5B for the HERV-K LTRs, and
HERVK-int for the internal HERV-K segments.
Thousand three hundred and sixty-one LTRs and 255 HERV-K
internal genome fragments were obtained. This is somewhat larger
than the number of loci assessed by Subramanian et al. (16) mainly
because RepeatMasker identified multiple fragments derived from
individual HERV-K genomes, and these were counted separately
here. RepeatMasker identified the fragments separately when
HERV-K loci were disrupted by deletions, insertions, or exten-
sive substitution mutations. In Figure 1, each locus was plotted as
a function of its length. The LTRs were mostly intact and not bro-
ken into fragments. The peak around 970 bp (Figure 1A) reflected
the size of the LTRs of the most recently acquired, Homo sapiens-
specific proviruses. In contrast, the viral internal genome segments
were mostly disrupted into smaller fragments (Figure 1B). Only 26
loci had full-length or near full-length internal sequences. HERV-
K proviruses were categorized as type I or II (51) depending on
the presence of a 292-bp stretch spanning the pol-env gene bound-
ary (type II) or the deletion of that segment (type I). The 26 loci
included 18 that fell into the 7,400- to 7,600-bp window, plus 8
type I proviruses where RepeatMasker separately identified the
5′ part of the internal sequences in the 5,400- to 5,600-bp win-
dow and the 3′ part in the 1,600- to 1,800-bp window. These
loci and a few additional loci relevant to this study are listed in
Table 1.
Similarly, the genomic coordinates for all known genes were
obtained using the knownGene table function in the UCSC
Genes track for whole genes, exons, introns, 5′ untranslated
regions (5′ UTRs), 3′ untranslated regions (3′ UTRs), and cod-
ing sequences (CDSs) (Table 2). Thirty-three percent of LTRs and
FIGURE 1 | Distribution by size of HERV-K components detected by
RepeatMasker in the UCSC Genome Browser, GRCh37/hg19 human
genome assembly. (A) Thousand three hundred and sixty-one HERV-K LTR
fragments are plotted as function of 20 bp length windows. (B) Two hundred
fifty-five HERV-K provirus internal genome segments are plotted as a function
of 200 bp length windows.
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Table 1 | Full-length HERV-K (HML-2) proviruses and their locations in the human genomea.
Provirus Type Length NCBI accession # Chrom. UCSC coordinatesa
K101 I 9,175 AF164609 22q11.21 18,926,187–18,935,361
K102 I 9,180 AF164610 1q22 155,596,457–155,605,636
K103b I 968 AF164611b 10p12.1 27,182,399–27,183,366
K104 II 9,446 AF164612 5p13.3 30,486,760–30,496,205
K105c 968 AF165235–AF165234d Un_g1000219 175,210–176,178
I 6,361 and JQ790992
K106 I 9,159 AF165240–AF165241d 3q13.2 112,743,124–112,752,282
K107/K10 I 9,180 AF164613 5q33.3 156,084,717–156,093,896
K108 II 17,975e AF164614 7p22.1 4,622,057–4,640,031
K109 II 9,422 AF164615 6q14.1 78,426,662–78,436,083
K110 I 9,232 AF165258–AF165259d 1q23.3 160,660,575–160,669,806
K111 I 9,160 GU476554 11q23.3 118,591,724–118,600,883
K112/K33 II 9,463 DQ112100 10p14 6,866,141–6,875,603
K113f AF387847–AF387849d 19p12 21,841,536–21,841,541f
II 9,473 and AY037928
K114/K36 II 9,466 DQ112101 11q22.1 101,565,794–101,575,259
K115 AF387846–AF387848d 8p23.1 7,355,397–7,364,859
II 9,463 and AY037929
K116/K50B I 9,180 DQ112147 3q27.2 85,280,336–185,289,515
K117/K41 II 9,457 DQ112140 12q14.1 58,721,242–58,730,698
K118/K(II) I 9,123 AB047240.1 3q12.3 101,410,737–101,419,859
K(I) II 9,138 AB047209 3q21.2 125,609,302–125,618,439
K4 I 6,373 DQ112097 1p31.1 75,842,771–75,849,143
K5 I 7,229 DQ112093 4q32.3 165,916,840–165,924,068
K50F II 9,518 DQ112151 19q13.12 37,597,549–37,607,066
K51 I 6,738 DQ112098 19p12 22,757,824–22,764,561
K60 I 9,657 DQ112108 21q21.1 19,935,621–19,940,996
3p12.3 II 8,685g NDh 3p12.3 75,600,465–75,609,150
4p16.1 II 9,594 NDh 4p16.1 9,659,580–9,669,174
K17B II 9,584 DQ112124 4p16.1 9,123,515–9,133,075
4p16.3 II 9,588 NDh 4p16.3 3,979,051–3,988,639
K7 II 9,554 DQ112131 11p15.4 3,468,656–3,478,209
8p23.1c II 9,527 NDh 8p23.1 12,073,970–12,083,497
K27 II 10,117 DQ112118 8p23.1 8,054,700–8,064,221
KO1D130352 II 9,516 DQ112134 8p23.1 12,316,492–12,326,007
aLocations in the human genome according to the UCSC Human Genome Assembly, February 2009 (GRCh37/hg19).
bK103 is present as a solo LTR in the genome assembly. The accession number is for the full-length provirus.
cK105 is present as a solo LTR (chrUn_gl000219:175,110–176,278) inserted in centromeric region (CER satellite) DNA.
dAccession numbers for the flanking sequences.
eK108 is present as a tandemly duplicated provirus in the genome assembly.
fK113 is absent from the genome assembly (GRCh37/hg19); coordinates for the duplicated target sequence at insertion site are annotated.
gMost of the 5′ LTR is deleted.
hThese proviruses are present in the UCSC Human Genome Assembly, February 2009 (GRCh37/hg19), but have not been characterized independently and do not
have accession numbers.
31% of internal HERV-K genome sequences were located within
transcribed portions of UCSC genes genes, which is similar to
the fraction of the human genome encompassed by the tran-
scribed portions of genes. Four percent of the viral loci overlap
with exons, mainly with untranslated regions (UTRs). Three of
the viral loci overlapped CDSs of putative human genes. None
of those three genes have been firmly characterized, and for
two of them, the overlapping segments were short. Details of
the overlaps are described below in the Section Materials and
Methods.
HERV-K TRANSCRIPTION IN PROSTATE CANCER CELL LINES
The general approach used to analyze HERV-K RNA expression
was to perform RT-PCR on RNAs isolated from prostate cancer cell
lines (Figure 2). These analyses were undertaken as part of ongo-
ing studies of these tumors. Primers were designed in conserved
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Table 2 | Location of HERV-K loci relative to human protein-coding genes and their components.
repName by
RepeatMasker
(total number)
Gene features
Intergenica (%)+
intragenic (%)
Coding
capacity
Gene (same:
opposite)
orientation
Exon (same:
opposite)
orientation
5′ UTR (same:
opposite)
orientation
3′ UTR (same:
opposite)
orientation
CDS (same:
opposite)
orientation
LTR5_Hs, LTR5A,
LTR5B (1,361)
906 (67%)+
455 (33%)
Coding 381 (99:284)b 16 (8:9)b 5 (3:2) 11 (5:6) 2 (0:2)
Non-coding 87 (53:36)b 20 (17:4)b – – –
HERVK-int (255) 175 (69%)+
80(31%)
Coding 56 (14:42) 5 (3:2) 2 (1:1) 2 (1:1) 1 (0:1)
Non-coding 24 (14:11)b 10 (9:2)b – – –
aIntergenic is defined as outside the transcribed portions of genes, and intragenic is defined as spanning the transcribed portion of a gene.
bA number of intersections were counted for both directions when a locus had two genes in transcribed in opposite directions.
FIGURE 2 | Structure of the HERV-K genome and spliced mRNAs
showing the primers used for reverse transcription and PCR. A genetic
map of a HERV-K provirus (darker gray) inserted into host genome (lighter
gray) is shown with target duplicated sequence (TDS) indicated as black
boxes. The unspliced primary viral transcript, 1×-spliced env mRNA and
2×-spliced rec mRNAs are shown below the viral genome with 3′ poly(A) tails
indicated (AAAA). The env mRNA shows the position of the 292-nt deletion
(∆292) of type I HERV-K proviruses that spans the pol-env junction. Type II
HERV-K provirus transcripts contain these nucleotides. Positions of the PCR
primer pairs are shown at the bottom with the names by which they are
identified throughout the paper. The dashed, angled line shows the excised
intronic sequences that the 1×-env primer pair was designed to cross.
stretches of viral sequences and were expected to amplify most
of the HERV-K loci in the human genome identified by Repeat-
Masker above. Nonetheless, it is possible that particular loci were
not recognized by the particular primer pairs used. Transcripts
were amplified using RNAs isolated from four PrCa cell lines. RT-
PCR using a primer pair to detect a 2-kb amplicon spanning the
pol-env junction in unspliced viral RNA (“unspliced,” Figure 2)
is shown in Figure 3A. Two kilobase products were detected in
all four PrCa cell lines. Parallel amplification reactions were per-
formed without RT and were uniformly negative, thus showing
that amplification was from RNA templates and not from any
potentially contaminating genomic DNA (Figure 3A). The larger
band in VCaP cells corresponded to that from type II proviruses,
while the smaller band observed in all four lines corresponded to
type I proviruses.
MULTIPLE HERV-K LOCI ARE ACTIVE
Individual proviruses inevitably accumulate unique mutations
over evolutionary time. These differences and the sequences flank-
ing the proviruses could affect the expression of specific HERV-K
loci. They can also be used to identify the specific viral loci
from which transcripts originated. Pairwise comparisons of the
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FIGURE 3 | Detection of HERV-K transcripts in four prostate cancer cell
lines. RT-PCR was performed to detect viral sense strand transcripts
specifically, and the products were resolved by electrophoresis. (A) RT-PCR
products from a primer pair designed to detect unspliced viral RNAs
(unspliced). (B) RT-PCR products from primers designed to detect RNAs
spliced at the conventional env mRNA splice junction (1×-env). Genomic
positions of the primers are shown in Figure 2. Parallel controls were
performed without reverse transcriptase (−RT) and with no added template
(NTC, no template control) as controls to exclude DNA contamination. DNA
size markers are shown on the left.
sequences of human-specific, HERV-K proviruses showed that
they were about 99% identical. Thus sequencing of the PCR prod-
ucts was necessary to identify the specific loci of origin for the
transcripts, and it is was important for the sequence reads to be
long enough to encompass the limited polymorphisms among
the newest proviruses in the human genome. Sequence reads were
matched to the closest HERV-K locus in the human genome. Many
sequence reads matched a genome provirus 100%. Some had one
or more mismatches, but all of these matched a genomic locus
by >99%. The differences may be due either to polymorphisms
among the HERV-K loci in the human population, the extent of
which is largely unknown, or to misincorporation errors during
RT-PCR. Both RT and the PCR polymerase can cause nucleotide
misincorporations.
To determine whether or not the HERV-K transcripts detected
in PrCa cells arose from a single HERV-K locus or multiple loci in
the human genome, the PCR products shown in Figure 3A were
sequenced (Table 3). Direct sequencing of the amplicons from
DU145 and LNCaP cells allowed identification of the transcripts
as containing mutations unique to HERV-K102 and HERV-K118
proviruses, respectively, thus showing that they derived princi-
pally from these loci (Table 3) (hereafter proviruses are called
simply K102, etc.). PC3 and VCaP showed mixed peaks in the
chromatographs, and thus the PCR products were shotgun cloned
into plasmid vectors, and at least seven individual clones of each
were sequenced. Both lines contained transcripts from K118, while
K102 was observed in PC3 and K50F was found in VCaP. Based
on the nearly equal mixed peak heights in the chromatographs
of the initial PCR products (data not shown), it is plausible to
estimate that the proportion of transcription of the two loci
Table 3 | Cell lines where transcripts from specific HERV-K proviruses
were detected.
Genomic locus PCR fragments (amplicons)
Unspliced 1×-enva
K118 (3q12.3) LNCaPb LNCaP
PC3c
VCaPc
K102 (1q22) DU145b –
PC3c
K50F (19q13.12) VCaPc –
K108 (7p22.1) – DU145
K60 (21q21.1) – PC3
aFrom direct sequencing of PCR products in Figure 3B.
bFrom direct sequencing of PCR products in Figure 3A.
cFrom sequencing of plasmid subclones of PCR products in Figure 3A.
was roughly comparable. In summary, the sequencing analysis
showed that the transcripts originated from at least three dif-
ferent HERV-K loci in the human genome, and that they par-
tially varied among the cell lines. The analysis detected only the
most abundant cDNAs that were amplified, and more extensive
sequencing might identify additional transcribed loci of lower
abundance.
SOME HERV-K TRANSCRIPTS ARE SPLICED IN PROSTATE CANCER CELL
LINES
In addition to assessing which proviruses had sufficient integrity
for the RNAs to be spliced, the detection of viral splicing would
provide further evidence that the RT-PCR products derived from
viral RNAs and not from any potentially contaminating DNA. To
investigate whether the HERV-K transcripts could be spliced, we
performed strand-specific RT-PCR across one of the viral splicing
junctions in the four PrCa cell line. Using primers designed to
detect the 1×-spliced env mRNA (Figure 2), three out of four cell
lines were found to be positive (Figure 3B), although the sizes of
the products were different in the different lines. To investigate the
basis for this, the products were sequenced (Table 3). This analysis
showed that a different locus was responsible for the predomi-
nant spliced cDNA product in each line, K108 in DU145, K118 in
LNCaP, and K60 in PC3.
K108 is one of the most intact HERV-K proviruses in the human
genome, having full-length ORFs for all viral proteins (2, 12).
Splicing of RNA from this provirus in DU145 cells occurred at the
canonical env mRNA splice sites in the viral genome (Figure 4).
Detection of the expected splice junction for K108 env mRNA
further confirmed that the RT-PCR products were derived from
RNA templates. Splicing for both K118 and K60 was detected
at unique, non-canonical sites, and the positions were differ-
ent for each (Figure 4). For K60 in PC3 cells, the 5′ splice site
matched the consensus sequence for the minor spliceosome (52)
and was located 435 nt downstream of the canonical 5′ splice
site. The 3′ splicing site matched no apparent consensus sequence
and was only 6 nt downstream of the canonical env mRNA 3′
splicing site. The alternative splice sites used and the presence
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FIGURE 4 | Human endogenous retrovirus K RNA splice sites determined
by sequencing of RT-PCR products. The 5′ and 3′ portions of a HERV-K
provirus are shown at the top separated by / and /. 5′SS and 3′SS indicate the
conventional splicing sites of HERV-K, and their positions are marked as black
circles. The positions of the outer PCR primers used for the nested PCR are
shown as arrows. Structures of the env spliced RT-PCR products from the cell
lines and proviruses indicated are diagrammed below the viral genome.
Dashed angled lines show the excised introns. Red circles show the positions
of the sequences where unconventional splicing occurred. For each spliced
product, the top sequence shows the inferred primary transcript sequence
determined from that of the cognate genomic locus, and the bottom
sequence shows the sequence of the RT-PCR product. Red nucleotides were
joined in the spliced product. Gray nucleotides show the ends of the excised
sequences. The positions of the 292-nt deletion definitive of type I proviruses
and a 164-nt deletion in the K60 provirus relative to other HERV-K proviruses
are shown.
or absence of the 292-bp pol-env junction characteristic of type
I HERV-K proviruses (Figure 4) accounted for the differences
in sizes of the RT-PCR products in Figure 3B. The absence of
unspliced products corresponding to K108 and K60 (Table 3)
may be due to unspliced transcripts from these proviruses being
less abundant than those from the other proviruses in these cells
and/or transcripts from these proviruses being more completely
spliced.
The spliced HERV-K products from DU145, LNCaP, and PC3
cells were not generated in the absence of RT (Figure 3B),
showing that they were indeed derived from RNA templates.
The possibility that they were derived from spliced pseudo-
genes was also considered by searching existing human genome
sequences for the sequences that we detected using BLAT. No
such products were detected. Moreover the splicing of K108
RNA exactly at the canonical sites as expected provided a con-
trol that expected splicing was detectable under the condi-
tions used. Thus it appears that the unexpected use of non-
canonical splice sites for some HERV-K transcripts accurately
reflected unusual splicing that occurred in the PrCa cell lines
used.
SOLO LTRs ARE ACTIVELY TRANSCRIBED
The question whether solo LTRs are transcribed was also
addressed. As these, like viral LTRs in general, contain the viral
U3 region transcriptional regulatory elements, they thus have
the potential to initiate transcription (53, 54). In addition, many
HERV-K solo LTRs are present within transcription units of cel-
lular genes and may be transcribed as segments of such units.
Since solo LTRs outnumber proviruses containing the viral inter-
nal sequences (16), we hypothesized that the levels of their RNAs
might be higher than those from HERV-K internal sequences.
If, alternatively, LTR transcripts were predominantly components
of longer viral transcripts originating from full-length HERV-K
proviruses, then the levels would be similar.
To answer this question, two-step, quantitative, RT-PCR was
performed with one primer pair designed in the LTR and one in
the env gene (q-LTR and q-env, Figure 2). The q-LTR pair was
positioned in the R portion of the LTR, and the q-env pair was
positioned so that it detected both unspliced and 1×-spliced env
mRNA. In all four PrCa cell lines, the average difference of thresh-
old cycle (Ct) between transcription levels of LTRs and env was
about 7.2 Ct (Figure 5), which corresponds to roughly 100-fold
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FIGURE 5 | Quantitative RT-PCR of HERV-K LTR and env sequences in
prostate cancer cell lines. Threshold cycle is shown for the viral
components in each cell line.
or greater levels of LTR RNA than unspliced or 1×-spliced RNA.
Since the unspliced and 1×-spliced RNAs have two copies of the
LTR R region for each copy of env (Figure 2), the great excess of
LTR transcripts presumably reflects a large excess of transcripts
derived from solo LTRs.
HERV-K ELEMENTS ARE TRANSCRIBED FROM BOTH STRANDS
Human endogenous retrovirus K LTRs, like those of other retro-
viruses, contain the viral enhancers and promoters that may
potentially drive transcription of the viral sense strand (53, 54).
They also contain signals for polyadenylation (55). In addition,
proviruses and solo LTRs may be integrated into other tran-
scription units and be transcribed as part of them (42). Thus
transcribed HERV-K sequences may arise from either the sense
strand, the antisense strand, or both, depending on where active
promoters are located. Viral sequence-containing transcripts may
include introns in pre-mRNAs, long non-coding RNAs, standard
viral transcripts, solo-LTR initiated RNAs, LTR-polyadenylated
transcripts, and even short RNAs of unknown significance. To
assess transcripts in the PrCa cell line more comprehensively, five
different primer pairs for short PCR amplicons were designed for
LTR, pro, and env genes (Figure 2). For the env gene, three non-
overlapping regions were used. Sequencing was used to identify
the loci of origin for the RNAs detected. By including either the
forward or the reverse primer separately during the reverse tran-
scription step, strand specificity of HERV-K transcripts could be
determined. RT-PCR was performed on LNCaP cells (Figure 6).
The primary PCR products were directly sequenced, and, in addi-
tion, the products were cloned into plasmid vectors, and 7–10
clones were sequenced for each PCR product (Table 4).
Analysis of sense strand transcripts from the internal por-
tion of the HERV-K genome in LNCaP cells showed that 27/27
clones derived from HERV-K118 (Table 4), similar to what was
observed above for the unspliced primer pair spanning the pol-
env junction (Table 3). In contrast, sequencing of products the
HERV-K antisense strand showed that they were derived from
at least five different loci, including full length, recently inserted,
HERV-Ks and more ancient HERV-K loci. Among these, the older
HERV-K(I) locus was the most frequently detected one during
FIGURE 6 | Reverse transcriptase-PCR analysis of HERV-K transcripts in
LNCaP cells. Strand-specific, RT-PCR was performed on RNA isolated from
LNCaP cells for five different positions in the HERV-K genome using the
primer pairs identified in Figure 2, and the products were resolved by
electrophoresis. Viral strand indicates RT-PCR products that originated from
viral sense (+) or antisense (−) RNAs. Parallel controls were performed
without reverse transcriptase (−RT) and without adding any RNA template
(NTC, no template control) to exclude DNA contamination. DNA size
markers are shown on the left.
the sequencing of plasmid clones that were derived from HERV-
K antisense transcripts (39%) (Table 4). Other proviruses from
which antisense transcripts were detected were K106, K50F, and
two unnamed, fragmented loci (Table 4). Two of the proviruses
identified by this approach, K50F and the fragment at 11q12.3,
are known to be inserted in introns of human genes and in
the opposite transcriptional orientation. Thus the viral antisense
strands for these might be a consequence of being within the pri-
mary transcripts of the host genes. The other four HERV-K loci are
not within introns of human genes, and the basis for transcription
of their antisense strands is unclear.
Reverse transcriptase-PCR products from the LTR region were
also analyzed (Table 4). Both strands of the HERV-K LTR were
represented. For 94% (17/18) of the clones sequenced, the best
genomic locus or loci matching the obtained sequences were not
in the LTRs of proviruses with internal viral sequences. Instead
one or more solo LTRs were the loci of origin. Since the primer
pair was in a well-conserved component (the R region) of LTR, it
was not always possible to assign a sequence uniquely to a single
solo LTR locus. Nonetheless, these data provided further evidence
proving that solo LTR transcription is widespread, in addition to
showing that transcripts of both the sense or antisense strands of
various HERV-K proviruses and solo LTRs were transcribed.
DISCUSSION
Human endogenous retrovirus K(HML2) transcripts were
detected in all four prostate cancer cell lines examined. These
included transcripts of both viral strands and transcripts that
were spliced. HERV-K transcripts were previously detected in
prostate cancer and include loci in addition to those identified
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Table 4 | Human endogenous retrovirus K proviruses detected in LNCaP cells by sequencing plasmid subclones.
Genomic locus Viral strand PCR fragments (amplicons)a
LTR pro env-1 env-2 env-3
K(I) (3q21.2) Rev 1/8 2/9 6/8 –b 5/7c
Fwd – – – – –
K106 (3q13.2) Rev – 1/9 – 3/9c 1/7
Fwd – – – – –
K50F (19q13.12) Rev – – 2/8 5/9 –
Fwd – – – – –
Fragment 11q12.3 Rev – – – 1/9 1/7
Fwd – – – – –
K118 (3q12.3) Rev – – – – –
Fwd – – 10/10c 10/10 7/7
Fragment 7q34 Rev – 6/9 – – –
Fwd – – – – –
Solo LTRs (multiple loci) Rev 7d/8c – – – –
Fwd 10/10c – – – –
aNumerators are the number of clones detected from the individual locus indicated, and denominators are the number of clones sequenced. Fwd and Rev indicate
whether the RNA matched the forward (sense) or reverse (antisense) strand of the viral DNA genome.
b–Indicates not detected.
cAmbiguous amplicon.
dIn this sample 2 sequences may belong to LTRs of full-length HERV-Ks or to solo LTRs but the sequence is ambiguous.
here (35, 45). The results here employed cDNA sequencing to dis-
tinguish from which among the highly similar HERV-K loci in the
human genome the most predominant transcripts arose. Certain
HERV-K loci in the human genome, K118 and K102, were tran-
scribed in multiple prostate cancer cell lines, raising the possibility
that the genomic insertion sites, mutations unique to them, and/or
epigenetic states of these proviruses make them prone to transcrip-
tion in these cells lines. Other HERV-K loci were detected only in
individual lines. However, detection here was limited by the num-
ber of plasmid clones sequenced, and deeper sequencing might
reveal transcripts from more HERV-K loci. Nonetheless the loci
identified here likely reflected the most abundantly transcribed loci
in these cell lines. This study emphasizes the importance of analyz-
ing HERV-K transcripts at the single nucleotide level to distinguish
the specific loci from which they originated.
An additional finding here was that HERV-K solo LTRs were
abundantly transcribed in these cell lines. This is not surprising in
that these are more abundant than HERV-K internal segments in
the human genome (16). However, their abundance complicates
identification of the specific, individual loci of origin, and their
detection raises questions about the mechanisms that cause them
to be transcribed. Many are present in introns of human coding
genes (Table 2), and one possibility is that they may be transcribed
as components of the primary transcripts of these genes.
One unexpected finding here was the less intact nature of
HERV-K internal genome segments relative to LTRs as detected
by RepeatMasker (Figure 1). The LTR sizes clustered around large,
full-length, and near full-length segments, while those of internal
genome segments clustered at the very low end (Figures 1A vs
1B). Multiple factors could contribute to the internal segments
being recognized as separate fragments by RepeatMasker. One
is that if a portion of a repeated element suffered sufficiently
extensive mutation over evolutionary time that RepeatMasker no
longer recognized that portion as part of the element, then the
two flanking segments of the element would be reported as differ-
ent fragments. Likewise, if genetic breakage and rejoining events
including insertions, deletions, or other rearrangements occurred,
then an element would be reported by RepeatMasker as separate
segments. The internal segment of HERV-K is longer than the LTR,
roughly 7,500 vs. 1,000 bp, respectively, and thus would be more
likely to have suffered mutations. The 1,361 LTR fragments encom-
passed 1,162,766 bp. The mean length of 864 bp corresponded
to about 86% of a full-length LTR or roughly 1.2 fragments per
LTR. The 255 HERV-K internal segment fragments encompassed
487,441 bp. The mean length of 1,911 bp corresponded to about
25% of a full-length internal segment or roughly 4 fragments
per internal genome segment. The difference between LTRs and
internal segments is greater than could be caused even if half the
internal HERV-K segments were type I proviruses (missing the
292-bp) and thus recognized as two fragments. There are many
potential explanations for this unexpected difference. One is that
RepeatMasker may detect some HERV-K internal fragments that
include some evolutionarily older and thus more fragmented,
HERV-K variants than it does with LTR segments. Another is
gene conversion. HERV-K LTRs have been well-documented to
undergo gene conversion events among paralogous LTR loci (4,
18, 56). The greater abundance of LTRs might have caused them
to undergo more inter-locus gene conversion events resulting in
more homogenous sequences and thus being recognized as intact
by RepeatMasker compared to internal segments. Other unprece-
dented and seemingly less plausible alternatives might include
different mutation rates or effects on host fitness. The genetic basis
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is for the unexpected difference between LTRs and internal seg-
ments requires further study and might turn out to be biologically
interesting.
Another unexpected finding was the detection of splicing at
non-standard sites. Use of the expected splice sites was observed
for K108 which is a type II provirus and one of the most intact
loci in the human genome, containing full-length ORFs for all
viral proteins (2, 12). The non-standard splicing involved type I
proviruses (K118 and K60). The 292-nt that are deleted in type I
HERV-K proviruses span a segment from just downstream of the
standard, env 3′-splice site and encompass the 5′-splice site for the
second intron of HERV-K (Figure 4). Perhaps this deletion and/or
other mutations in these proviruses affect splice site usage.
These studies bear on long term goals of understanding HERV-
K expression in cancer cells, and possibly exploiting it for T-cell
based immunotherapy in combination with conventional chemo-
RT therapy. The detection of HERV-K transcripts in prostate
cancer cell lines adds to the list of human tumors in which RNAs
from this retrovirus have been observed and raises the point that
further study of the virus in this disease is warranted, as it is in
other diseases. Immune responses against HERV antigens have
been reported in human diseases (27, 28, 33, 57–59), and such
responses might be of significance for certain types of human
cancers if HERV-K is expressed. Detailed analyses such as those
performed here provide a step toward clarifying the spectrum of
HERV-K expression in human tumor cells.
MATERIALS AND METHODS
DETERMINATION OF HERV-K LOCUS NUMBER AND SIZE IN HUMAN
GENOME
The Table Browser tool (47) at UCSC Genome Browser (62) web-
site1 was used to download the sequences and genomic positions of
HERV-K elements in the human genome sequence. RepeatMasker
(49) definitions based on RepBase (50) were filtered by repName
matching for LTR5_Hs, LTR5A, or LTR5B for the HERV-K LTRs
and HERVK-int for proviral internal HERV-K genome segments.
R software (60)2 was used to plot the loci against their size for
LTRs (Figure 1A) and HERVK-int (Figure 1B).
Similarly, the genomic coordinates for all known genes in
human genome were obtained using knownGene in UCSC Genes
track, separately for whole gene, exons, introns, 5′ UTRs, 3′ UTRs,
and CDSs. The HERV-K and gene coordinate data were uploaded
on Galaxy (61)3 for further analysis. To determine the overlap of
each locus with annotated genes in the human genome, we used
the Intersect tool (version 1.0.0) to compare genomic positions of
HERV-K loci with known genes and their subcomponents (exons,
introns, 5′ UTRs, 3′ UTRs, and CDSs). Intersection of at least 1 nt
was considered as overlapping to generate the data summarized in
Table 2.
The finding that three HERV-K fragments overlapped with
CDSs was unexpected and was analyzed further. In one instance,
a 772-bp fragment of a solo LTR was found to be located in the
TBC1D29 gene on chromosome 17. The LTR fragment was in the
opposite orientation as the gene, and the 3′ end of the fragment
1http://genome.ucsc.edu/
2http://www.R-project.org
3http://galaxyproject.org/
comprised the last 19 coding nucleotides of the ORF, two tandem
stop codons, and the small 3′ UTR of one isoform of TBC1D29.
This gene is a novel, putative TBC-1 domain protein, which are a
family of Rab-GAP GTPase activator proteins.
A second instance was only a short 49 bp LTR_5B segment in
the opposite orientation as gene R3HCC1 on chromosome 8. The
LTR segment formed the 3′ part of the second coding exon of
the gene, through the third nucleotide before the splice junction.
Multiz alignments on the UCSC Genome Browser showed that
a similar sequence was in the rhesus macaque (Macaca mulatta)
genome assembly, and no comparable element has been found
for mouse and dog, consistent with a HERV-K insertion after
the catarrhine divergence from other primates. However, simi-
lar sequences also have been identified for elephant and opossum.
In particular, the elephant sequence encoded an identical amino
acid sequence except at one position, which is not consistent with
a HERV-K element. Given the short extent of this sequence and
the apparent existence of orthologous sequences in elephant and
opossum, it is difficult to discern if this is a bona fide HERV-K
segment or an unusual sequence convergence, and caution should
be reserved.
The third was a viral internal segment that overlapped a cDNA
encoding a single exon transcript AX747630 on chromosome 17
with an ORF encoding 180 amino acids. The N-terminal 98 amino
acids of the HERV-K Gag protein provided the first portion of the
putative human protein. The same HERV-K insertion was present
in the rhesus macaque genome assembly, and the CDSs of the
human and macaque ORFs were 84% identical. Whether a real
protein is produced from the ORF, and whether or not it has any
function are unknown.
CELL LINES AND CULTURE CONDITIONS
Four PrCa cell lines (LNCaP, DU145, PC3, and VCaP) were pur-
chased from ATCC (Manassas, VA, USA). Cell lines were grown in
5% CO2 in a humidified 37 °C incubator to 90% confluence.
RNA EXTRACTION
Total RNA was extracted using Trizol (Invitrogen). RNA was
then subjected to DNAse-I digestion (TURBO DNA-free kit –
Applied Biosystems #AM1907) to remove any genomic DNA con-
tamination. RNA quality and concentration were determined by
evaluation of rRNA bands in agarose gel electrophoresis and by
NanoDrop spectrophotometric analysis (Thermo Scientific).
RT-PCR AND SEQUENCING
To identify the specific active HERV-K loci, 1µg of each RNA was
used for gene-specific RT-PCR. Primers were designed in well-
conserved segments of HERV-K genome to ensure amplification
of as many loci as possible. A set of primers was designed across
the viral env splicing junction to identify the singly spliced vari-
ant of HERV-K transcript. Parallel controls were performed to
detect beta-actin and GAPDH transcripts. Primer sequences were
as follows:
unspliced-Fwd: 5′-CTGGTGCATGGAAGATTGGT-3′
unspliced-Rev: 5′-CACCGCACTATTGGCCACA-3′
1×-env(1)-Fwd: 5′-AGGGAAAAACCGCCTTAGGG-3′
1×-env(1)-Rev: 5′-CACCGCACTATTGGCCACA-3′
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1×-env(2)-Fwd: 5′-TGCGGGCAGCAATACTGCT-3′
1×-env(2)-Rev: 5′-CGCACTATTGGCCACACATTC-3′
LTR-Fwd: 5′-CGTGGGAAGGGAAAGACCTGA-3′
LTR-Rev: 5′-AGCAGACAAACATGTGAACAAAGG-3′
pro-Fwd: 5′-CCCCACAAAACCCCCACAG-3′
pro-Rev: 5′-GATTTCCGCACCCCATTGTTG-3′
env-1-Fwd: 5′-CATGGTAAGCGGGATGTCACT-3′
env-1-Rev: 5′-CACCGCACTATTGGCCACA-3′
env-2-Fwd: 5′-GTGTGGCCAATAGTGCGGT-3′
env-2-Rev: 5′-ATTCCTTTTTCTCCCCATTCCCAG-3′
env-3-Fwd: 5′-GCTGGTGAGAGCAAGAGAGG-3′
env-3-Rev: 5′-CAATGCAACTCCTGCTACAGC-3′
q-env-Fwd: 5′-TCACATGGTAAGCGGGATGTC-3′
q-env-Rev: 5′-CGCACTATTGGCCACACATTC-3′
q-LTR-Fwd: 5′-AGGGAAAAACCGCCTTAGGG-3′
q-LTR-Rev: 5′-AGCAGACAAACATGTGAACAAAGG-3′
hACTB-Fwd: 5′-CTGGCACCACACCTTCTACA-3′
hACTB-Rev: 5′-GCTGGGGTGTTGAAGGTCT-3′
hGAPDH-Fwd: 5′-AGATCATCAGCAATGCCTCCT-3′
hGAPDH-Rev: 5′-AGTCTTCTGGGTGGCAGTG-3′
The reverse transcription reactions (SuperScript III First-
Strand Synthesis System – Invitrogen #18080-051) were performed
using 1µg RNA in an initial volume of 10µL with 1µL of dNTP
mix 10 mM, gene-specific primer for a final concentration of 2µM
and DEPC-treated water. After an initial denaturation step, 5 min
at 65°C followed by 1 min at 4°C, 2µL of 10× RT buffer, 4µL of
25 mM MgCl2, 2µL of 0.1 M DTT, 40 U RNaseOUT, and 200 U
SuperScript III RT enzyme were added to reach a final volume
of 20µL. Gene-specific primers used were unspliced-Rev and
1×-env(1)-Rev for experiments shown in Figure 3; LTR-Rev, pro-
1-Rev, env-1-Rev, env-2-Rev, and env-3-Rev for experiments to
detect viral plus strand transcripts in Figure 6; and LTR-Fwd,
pro-1-Fwd, env-1-Fwd, env-2-Fwd, and env-3-Fwd for experi-
ments to detect viral minus strand transcripts in Figure 6. The
RT elongation step was performed at 50°C for 50 min, followed
by enzyme heat inactivation at 85°C for 5 min. After brief cooling
of the sample at 4°C, digestion of residual RNA was performed
with RNAse-H 2 U at 37°C for 20 min. Parallel experiments in
which no RT enzyme was added were simultaneously carried
out.
PCR was performed with 2µL of RT product, 200 nM primers
200, Platinum PCR SuperMix (Invitrogen), and nuclease-free
water to a total volume of 20µL. After a denaturation step at
94°C for 2 min, 30 cycles of denaturation-annealing-elongation
were performed, followed by final elongation at 72°C for 5 min.
Denaturation was performed at 94°C for 25 s, annealing for 25 s,
and extension at 72°C for each experiment as follows. Detec-
tion of unspliced amplicon (Figure 2A) was performed with
annealing temperature of 58°C followed by extension time of
2.5 min. Detection of 1×-env amplicon (Figure 2B) was per-
formed with a reaction at annealing temperature of 58°C fol-
lowed by extension time of 3 min, 2µL of a 1:200 dilution of
the PCR product was then used in nested PCR reaction with
the 1×-env(2) primers, and annealing temperature of 61°C fol-
lowed by extension time of 3 min. Detection of LTR, pro, env-1,
env-2, and env-3 amplicons (Figure 6) was performed with
annealing temperature of 55°C followed by extension time of
1 min.
Electrophoresis of PCR products was performed in 1% agarose
gels, PCR products obtained were purified (PCR purification –
Qiagen), and recovered cDNA was sequenced. PCR products were
cloned (TOPO TA cloning – Invitrogen Inc.) into pCR4 plasmids
using MACH-1 competent cells and sequenced.
IDENTIFICATION OF HERV-K LOCI
Each sequence obtained, trimmed of any vector and primers
sequences, was aligned to the human genome using BLAT soft-
ware (62). The sequence was assigned to the locus obtaining the
highest identity score (Tables 3 and 4). If more than one locus had
the same identity score, the sequence was considered ambiguous
(Table 4). All sequences meeting the minimum length requirement
of GenBank (>200 bp) were submitted there (accession numbers
KF254334–KF254392).
QUANTITATIVE RT-PCR
To quantify HERV-K transcripts, 1µg of RNA from each set was
used for two-step, quantitative RT-PCR (qRT-PCR) (Superscript
III First-Strand – Invitrogen) and PowerSybr Green (Applied-
Biosystems). RT (SuperScript III First-Strand Synthesis System –
Invitrogen #18080-051) of 1µg RNA was performed in an initial
volume of 10µL with 1µL of 10 mM dNTP mix, 1µL of 50µM
Oligo(dT)20 primer, and DEPC-treated water. After an initial
denaturation step of 5 min at 65°C followed by 1 min at 4°C, 2µL
of 10× RT buffer, 4µL of 25 mM MgCl2, 2µL of 0.1 M DTT, 40 U
RNaseOUT, and 200 U SuperScript III RT enzyme were added to
reach a final volume of 20µL. The RT elongation step was per-
formed at 50°C for 50 min, followed by enzyme heat inactivation
at 85°C for 5 min. After brief cooling of the sample at 4°C, diges-
tion of residual RNA was performed with 2 U RNAse-H at 37°C
for 20 min. Parallel experiments with no RT enzyme were carried
out simultaneously.
One microlitter of a 1:10 dilution of the RT product was
then added to 2× SYBR Green PCR Master Mix (AppliedBiosys-
tems #4367659) and nuclease-free water to a final volume of
8µL. Primers q-env-Fwd and q-env-Rev were designed in a well-
conserved region of HERV-K genome common to unspliced and
once-spliced transcript variants downstream of the∆292 deletion
characteristic of type I HERV-Ks. Primers q-LTR-Fwd and q-LTR-
Rev were designed in a well-conserved region of HERV-K LTR
corresponding to the R region. Two housekeeping genes, human
beta-Actin (hACTB) and human GAPDH (hGAPDH), were used
as endogenous controls for normalization. Three replicates per
sample were used in 384-well plate PCR system (7900HT –
AppliedBiosystems) with cycling conditions of 50°C for 2 min,
95°C for 10 min, 40 cycles of 95°C for 10 s, 60°C for 20 s and
72°C for 30 s. Data analysis was performed with SDS 2.4 software
(AppliedBiosystems).
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